Not Yet Recruiting
Orlistat Overcoming Third-generation EGFR-TKI Resistance
NCT06818955
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
- Locations
-
Not specified
Clinical trial condition
Osimertinib
Explore clinical trials studying Osimertinib. Study availability and eligibility vary by location and protocol.
2 public trials
0 recruiting studies
Osimertinib trial results
Active, Not Recruiting
Osimertinib Combined With Intracranial SRT for EGFR-Mutant NSCLC With Symptomatic Brain Metastases
NCT07491211
- Conditions
- Brain Diseases, Brain Metastases From Non-small Cell Lung Cancer (NSCLC), Brain Neoplasms, +17 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, China
- Wuhan Tongji Hospital Wuhan, Hubei, China
- Shanghai Jiao Tong University Affiliated Chest Hospital Shanghai, China